Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
This is a multicenter, randomized, prospective, Phase III study in which patients with advanced breast carcinoma previously treated with anthracyclines and taxanes will be randomly assigned to receive one of two treatment options: vinorelbine (Arm A) or gemcitabine plus vinorelbine (Arm B).
Epistemonikos ID: 61a08c87be388c606b63acef809063de4777137c
First added on: May 04, 2024